Journal Information
Vol. 15. Issue 1.
Pages 96 (January - February 2011)
Share
Share
Download PDF
More article options
Vol. 15. Issue 1.
Pages 96 (January - February 2011)
Letter to the editor
Open Access
Fosfomycin in vitro resistance of Escherichia coli from the community
Visits
2494
Caroline M. Biondo1, Jaime L. Rocha2, Felipe Francisco Tuon3,
Corresponding author
flptuon@gmail.com

Correspondence to: Infectious and Parasitic Diseases Clinic Hospital Universitário Evangélico de Curitiba Alameda Augusto Stellfeld 1908, 3°. andar 80730-150 SCIH - Bigorrilho, Curitiba, Brazil.
1 Division of Infectious and Parasitic Diseases, Hospital Universitario Evangelico de Curitiba, Curitiba, PR, Brazil - MS
2 Division of Microbiology, Frischmann Aisengart/DASA Medicina Diagnóstica, Curitiba, PR, Brazil - MD
3 Hospital Universitário Evangélico de Curitiba
This item has received

Under a Creative Commons license
Article information
Full text is only aviable in PDF
References
[1.]
CLSI.
Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20.
Clinical and Laboratory Standards Institute, (2010),
[2.]
M. Popovic, D. Steinort, S. Pillai, C. Joukhadar.
Fosfomycin: an old, new friend?.
Eur J Clin Microbiol Infect Dis, 29 (2010), pp. 127-142
[3.]
E. Calbo, V. Romani, M. Xercavins, et al.
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
J Antimicrob Chemother, 57 (2006), pp. 780-783
[4.]
S. Superti, C.A. Dias, P.A. d‘Azevedo.
In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis.
Braz J Infect Dis, 13 (2009), pp. 123-124
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools